Thennati R[au] - Search Results

Year	Number of Results
2008	1
2011	2
2014	1
2017	1
2018	1
2021	1
2022	2
2023	2
2024	3

1

Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.

Singuru G, Pulipaka S, Shaikh A, Balaji Andugulapati S, Thennati R, Kotamraju S. Singuru G, et al. Among authors: thennati r. Int Immunopharmacol. 2023 Nov;124(Pt B):111070. doi: 10.1016/j.intimp.2023.111070. Epub 2023 Oct 18. Int Immunopharmacol. 2023. PMID: 37862737

2

In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist.

Jones B, Burade V, Akalestou E, Manchanda Y, Ramchunder Z, Carrat G, Nguyen-Tu MS, Marchetti P, Piemonti L, Leclerc I, Thennati R, Vilsboll T, Thorens B, Tomas A, Rutter GA. Jones B, et al. Among authors: thennati r. Diabetes Obes Metab. 2022 Nov;24(11):2090-2101. doi: 10.1111/dom.14794. Epub 2022 Jul 18. Diabetes Obes Metab. 2022. PMID: 35676825 Free PMC article.

3

Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation.

Pulipaka S, Singuru G, Sahoo S, Shaikh A, Thennati R, Kotamraju S. Pulipaka S, et al. Among authors: thennati r. Geroscience. 2024 Apr;46(2):2391-2408. doi: 10.1007/s11357-023-01015-w. Epub 2023 Nov 16. Geroscience. 2024. PMID: 37968424 Free PMC article.

4

Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe^-/- mice.

Karnewar S, Pulipaka S, Katta S, Panuganti D, Neeli PK, Thennati R, Jerald MK, Kotamraju S. Karnewar S, et al. Among authors: thennati r. Atherosclerosis. 2022 Sep;356:28-40. doi: 10.1016/j.atherosclerosis.2022.07.012. Epub 2022 Jul 20. Atherosclerosis. 2022. PMID: 35961209

5

Allergic rhinitis: an update on disease, present treatments and future prospects.

Mandhane SN, Shah JH, Thennati R. Mandhane SN, et al. Among authors: thennati r. Int Immunopharmacol. 2011 Nov;11(11):1646-62. doi: 10.1016/j.intimp.2011.07.005. Epub 2011 Jul 23. Int Immunopharmacol. 2011. PMID: 21784174 Review.

6

A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent.

Shaikh A, Neeli PK, Singuru G, Panangipalli S, Banerjee R, Maddi SR, Thennati R, Bathula SR, Kotamraju S. Shaikh A, et al. Among authors: thennati r. Chem Commun (Camb). 2021 Nov 19;57(92):12329-12332. doi: 10.1039/d1cc03497a. Chem Commun (Camb). 2021. PMID: 34740232

7

Analytical characterization of recombinant hCG and comparative studies with reference product.

Thennati R, Singh SK, Nage N, Patel Y, Bose SK, Burade V, Ranbhor RS. Thennati R, et al. Biologics. 2018 Jan 30;12:23-35. doi: 10.2147/BTT.S141203. eCollection 2018. Biologics. 2018. PMID: 29430170 Free PMC article.

8

Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis.

Pulipaka S, Chempon H, Singuru G, Sahoo S, Shaikh A, Kumari S, Thennati R, Kotamraju S. Pulipaka S, et al. Among authors: thennati r. Mech Ageing Dev. 2024 Mar 28:111931. doi: 10.1016/j.mad.2024.111931. Online ahead of print. Mech Ageing Dev. 2024. PMID: 38554949

9

Correction to: Therapeutic efficacies of mitochondria‑targeted esculetin and metformin in the improvement of age‑associated atherosclerosis via regulating AMPK activation.

Pulipaka S, Singuru G, Sahoo S, Shaikh A, Thennati R, Kotamraju S. Pulipaka S, et al. Among authors: thennati r. Geroscience. 2024 Apr;46(2):2801. doi: 10.1007/s11357-023-01049-0. Geroscience. 2024. PMID: 38146018 Free PMC article. No abstract available.

10

Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.

Thennati R, Khanna A, Khanna M, Sonaiya T, Mehta T, Mehta K, Shahi P, Patel J. Thennati R, et al. Clin Pharmacol Drug Dev. 2014 Nov;3(6):428-38. doi: 10.1002/cpdd.136. Epub 2014 Aug 28. Clin Pharmacol Drug Dev. 2014. PMID: 27129118 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year